Sanofi India Ltd

Sanofi India Ltd

₹ 9,197 0.78%
21 Feb - close price
About

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.

Key Points

India - Branded generics (79% of CY20 revenues):[1] Top-7 brands contribute ~70% of domestic sales and are growing at high single digits.[2]

  • Market Cap 21,175 Cr.
  • Current Price 9,197
  • High / Low 9,320 / 5,330
  • Stock P/E 36.9
  • Book Value 314
  • Dividend Yield 2.11 %
  • ROCE 41.4 %
  • ROE 30.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.0%
  • Company has been maintaining a healthy dividend payout of 169%

Cons

  • Stock is trading at 29.2 times its book value
  • The company has delivered a poor sales growth of 2.40% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
687 720 725 789 754 688 707 699 692 672 736 706 715
494 553 536 542 556 561 512 538 510 505 507 528 506
Operating Profit 192 167 189 247 199 127 194 161 182 167 230 178 208
OPM % 28% 23% 26% 31% 26% 18% 28% 23% 26% 25% 31% 25% 29%
15 24 26 17 504 16 142 16 11 34 44 16 12
Interest 0 0 0 0 0 0 0 0 0 0 0 1 0
Depreciation 21 20 20 21 14 11 11 11 10 10 10 10 10
Profit before tax 186 170 195 243 688 132 326 166 182 190 264 183 210
Tax % 29% 28% 25% 26% 23% 32% 27% 27% 28% 31% 28% 33% 28%
133 123 146 178 530 90 238 120 131 131 190 123 152
EPS in Rs 57.71 53.41 63.35 77.42 230.04 39.25 103.51 52.28 56.84 56.84 82.67 53.36 66.09
Raw PDF
Upcoming result date: 23 February 2024

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 TTM
1,301 1,573 1,809 1,977 2,193 2,367 2,460 2,771 3,071 2,902 2,957 2,770 2,829
1,141 1,261 1,411 1,639 1,817 1,832 1,921 2,146 2,403 2,186 2,194 2,066 2,046
Operating Profit 160 312 398 339 376 535 538 625 667 716 762 704 784
OPM % 12% 20% 22% 17% 17% 23% 22% 23% 22% 25% 26% 25% 28%
156 41 83 131 218 66 79 88 33 45 564 204 105
Interest 0 1 0 0 0 2 1 1 0 2 2 2 2
Depreciation 31 90 92 97 113 119 102 103 100 82 67 42 39
Profit before tax 284 262 388 373 481 480 515 610 600 677 1,258 864 847
Tax % 33% 32% 32% 29% 33% 37% 37% 38% 31% 29% 25% 28%
191 177 265 264 322 304 326 381 414 478 944 621 596
EPS in Rs 83.01 76.71 115.14 114.46 139.60 132.09 141.55 165.26 179.85 207.38 410.06 269.47 258.96
Dividend Payout % 40% 43% 39% 39% 46% 51% 50% 51% 194% 176% 119% 211%
Compounded Sales Growth
10 Years: 6%
5 Years: 2%
3 Years: -3%
TTM: 2%
Compounded Profit Growth
10 Years: 12%
5 Years: 10%
3 Years: 5%
TTM: 16%
Stock Price CAGR
10 Years: 13%
5 Years: 9%
3 Years: 5%
1 Year: 70%
Return on Equity
10 Years: 20%
5 Years: 23%
3 Years: 26%
Last Year: 30%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Jun 2023
Equity Capital 23 23 23 23 23 23 23 23 23 23 23 23 23
Reserves 1,094 1,181 1,324 1,463 1,604 1,860 2,003 2,196 2,419 2,096 2,203 1,253 701
0 0 0 0 0 0 0 0 0 23 25 24 20
386 427 532 742 778 658 751 765 802 777 811 772 754
Total Liabilities 1,503 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,498
737 699 699 648 877 817 769 733 499 464 334 306 316
CWIP 23 43 136 210 22 34 30 21 17 10 13 24 10
Investments 0 0 0 0 0 0 0 0 0 0 0 0 2
742 888 1,043 1,369 1,505 1,690 1,978 2,230 2,728 2,444 2,714 1,743 1,170
Total Assets 1,503 1,631 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,498

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022
205 290 273 265 213 322 435 374 412 611 559 399
-479 -5 -335 61 36 -155 -79 -73 66 276 631 651
-147 -90 -105 -122 -147 -180 -188 -197 -183 -810 -849 -1,583
Net Cash Flow -421 195 -168 205 102 -13 168 104 295 78 341 -533

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2011 Dec 2012 Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022
Debtor Days 29 23 24 21 24 22 29 21 27 19 18 17
Inventory Days 150 135 151 179 173 169 151 154 127 107 110 125
Days Payable 87 75 83 122 81 79 119 110 100 93 105 109
Cash Conversion Cycle 92 83 92 78 115 112 61 65 54 33 22 33
Working Capital Days 21 3 43 26 9 79 17 18 35 -7 -19 -18
ROCE % 27% 23% 29% 22% 26% 27% 26% 29% 28% 32% 35% 41%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
11.54% 10.87% 10.34% 9.22% 8.99% 8.71% 8.26% 6.99% 6.71% 6.72% 6.80% 6.31%
17.18% 17.41% 17.67% 19.05% 18.65% 18.59% 18.28% 19.22% 19.46% 19.65% 21.68% 20.83%
10.89% 11.33% 11.59% 11.33% 11.96% 12.30% 13.08% 13.41% 13.43% 13.22% 11.10% 12.46%
No. of Shareholders 48,46553,56751,64650,91659,27664,54273,73474,59376,69471,51368,59862,870

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents